Study supports Vertebene for spine function

By Olivia Haslam

- Last updated on GMT

© andreswd / GettyImages
© andreswd / GettyImages
Consumption of a multi-nutrient supplement might not only stabilize lumbar osteochondrosis progression but may also potential increase intervertebral disc volumes, according to a new study.

"The rationale for using the specific mix of nutritional substances including collagen type II, hyaluronic acid, n-acetyl-glucosamine, bamboo extract, L-lysine and vitamin C is the assumption that combining naturally occurring ingredients of the intervertebral disc would maintain spine function," the team of Austrian researchers wrote in the journal Nutrients​.

The study, funded by Austrian supplement manufacturer Natural Products & Drugs GmbH, investigated the effects of the company's Vertebene-branded supplement compared to placebo in 50 patients for three months. 

Supplements for back pain

Lumbar osteochondrosis, often associated with degeneration of the intervertebral disc (IVD), is a significant cause of lower back pain and loss of function​. 

Its causes are not fully understood but are thought to involve a mix of genetic, anatomical, traumatic, nutritional, inflammatory and metabolic factors.

While some research​ has shown positive treatment outcomes with nutrition interventions, the researchers on the current study noted that investigations of non-surgical treatment options are rare and that to their knowledge, no published trials have evaluated the effectiveness of such a specific nutritional supplement compared to placebo in a proper randomized trial setting. 

Improved back health

Participants with MRI-confirmed lumbar osteochondrosis were recruited and split into two groups, receiving either two daily capsules of Vertebene or a placebo. 

Each Vertebene capsule contained 300 mg collagen hydrolysate, 180 mg collagen type II, 90 mg mucopolysaccharides, 30 mg hyaluronic acid, 100 mg n-acetyl-glucosamine, 70 mg bamboo extract, 25 mg L-lysine hydrochloride and 30 mg vitamin C.

Outcomes were collected through self-reported scores questionnaires, and magnetic resonance imaging (MRI) was used to evaluate degenerative changes of IVD. Data were collected at baseline and after the three month intervention. 

None of the report scores were significantly different between the supplement and placebo groups, and disc degeneration remained stable during the intervention in both groups.

However, in-depth evaluations of MRIs showed significantly higher 3D-measured volume changes of disk in the supplement group compared to lower 3D-measured volume changes in the placebo group.

The researchers suggested that all ingredients in the formulation contributed to supporting joint health, bone structure and connective tissue: 

The result "marks an important step for a better understanding of the clinical relevance of supplements," the authors concluded, adding that further studies should increase the sample size and duration of intervention.

 

Journal: Nutrients
doi: 10.3390/nu16162695​ 
“A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study."
Authors: Laky, B. et al. 

Related products

show more

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

13X Boost in Glutathione with LipoAvail™

13X Boost in Glutathione with LipoAvail™

Content provided by Effepharm Ltd | 18-Sep-2024 | Product Brochure

Glutathione is a powerful antioxidant and vital metabolic regulator within cells. But it is unstable, susceptible to light, humidity, heat, gastric acid,...

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Related suppliers

Follow us

Products

View more

Webinars